Truist Financial Initiates Coverage on DexCom (NASDAQ:DXCM)
Investment analysts at Truist Financial started coverage on shares of DexCom (NASDAQ:DXCM – Get Free Report) in a report released on Monday, Marketbeat.com reports. The brokerage set a “buy” rating and a $102.00 price target on the medical device company’s stock. Truist Financial’s price target indicates a potential upside of 24.65% from the company’s previous […]
Investment analysts at Truist Financial started coverage on shares of DexCom (NASDAQ:DXCM – Get Free Report) in a report released on Monday, Marketbeat.com reports. The brokerage set a “buy” rating and a $102.00 price target on the medical device company’s stock. Truist Financial’s price target indicates a potential upside of 24.65% from the company’s previous […]
